The Kuala Lumpur Federal Court supported the appeal court and gave doctors the right to break down Ever Mectin.
Tun Tengku MAIMUN TUAN MAT Chief Justice said that when dismissing the appeal of the Ministry of Health, Ivermectin was classified as Group B Dok and that registered medical workers could sell, supply or manage them for treatment.
In August 2023, the three -member court court argued that the unanimously registered medical workers could disassemble the Ibe Mectin only for medical treatment and to comply with section 19 of Poisons Act 1952 and Dok Regulations 1952.
Tungku MAIMUN said, “In Article 21 (2), the entire procedure for prescriptions and how such poison (drug consideration) are sold or supplied to the patient for the treatment of the patient,” said Tunku My Moon.
She said the federal court agreed to submit the respondents in accordance with Section 19, and all registered medical workers were allowed to disassemble the patient to disassemble the patient for treatment.
The initial appeal court ruling was based on two questions raised by Dr. S Vijaendran, president of the Malaysian Association, and Dr. CHE Amir Farid CHE Isahak.
The problem includes whether the medical practitioners registered in the Poisons Act 1952 and Poisons RegulationS 1952 can distribute ibermectin into ingredients to the patient.
Another question was whether the registered medical care was aimed at the patient’s medical treatment and the ACT and regulations could be disassembled to the patient.
In March 2022, the High Court dismissed a doctor’s lawsuit, but this year was overturned by the Court of Appeals. -N March 3, 2025
